4th Quarter - Report

ARENTFOX SCHIFF LLP for SANBIO, INC.

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to regenerative medicine advanced therapies

Foreign entity interest: SanBio Company Limited, identified in the LD-1, is interested in U.S. health care policies that may affect the business of its subsidiary SanBio, Inc.

LobbyistCovered position, as disclosed
SONJA NESBIT —
DAN RENBERG —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.